The impact of fingolimod (FTY720) in neuroimmunologic diseases: Mechanisms beyond immunomodulation

American Journal of Pathology

Volumn 176, Issue 6, 2010, Pages 2599-2601

  Haghikia, Aiden ^a   Gold, Ralf ^a  

^a ST JOSEF HOSPITAL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

FINGOLIMOD; SPHINGOSINE 1 PHOSPHATE; IMMUNOSUPPRESSIVE AGENT; PROPANEDIOL DERIVATIVE; SPHINGOSINE; SPHINGOSINE 1 PHOSPHATE RECEPTOR;

CELL INTERACTION; CELL MATURATION; CELL MEMBRANE; CELL SURVIVAL; CONFOCAL MICROSCOPY; DRUG MECHANISM; ELECTRON MICROSCOPY; IMMUNOMODULATION; IMMUNOPATHOLOGY; MICROSCOPY; MYELINATION; NEUROIMMUNOLOGIC DISEASE; NEUROLOGIC DISEASE; NONHUMAN; NOTE; OLIGODENDROGLIA; PRIORITY JOURNAL; ANALOGS AND DERIVATIVES; HUMAN; IMMUNOLOGY; METABOLISM; MULTIPLE SCLEROSIS; NERVE CELL;

HUMANS; IMMUNOMODULATION; IMMUNOSUPPRESSIVE AGENTS; MULTIPLE SCLEROSIS; NEURONS; OLIGODENDROGLIA; PROPYLENE GLYCOLS; RECEPTORS, LYSOSPHINGOLIPID; SPHINGOSINE;

EID: 77953211778     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.2353/ajpath.2010.100200     Document Type: Note

References (16)

1. Kappos L, Radue EW, O'Connor P, Polman C, Hohlfeld R, Calabresi P, Selmaj K, Agoropoulou C, Leyk M, Zhang-Auberson L, Burtin P (FREEDOMS Study Group): A placebo-controlled trial of oral fingolimod in relapsing multiple sclerosis. N Engl J Med 2010, 362:387-401
2. Cohen JA, Barkhof F, Comi G, Hartung HP, Khatri BO, Montalban X, Pelletier J, Capra R, Gallo P, Izquierdo G, Tiel-Wilck K, de Vera A, Jin J, Stites T, Wu S, Aradhye S, Kappos L (TRANSFORMS Study Group): Oral fingolimod or intramuscular interferon for relapsing multiple sclerosis. N Engl J Med 2010, 362:402-415
3. Schwab SR, Cyster JG: Finding a way out: lymphocyte egress from lymphoid organs. Nat Immunol 2007, 8:1295-1301
4. Miron VE, Ludwin SK, Darlington PJ, Jarjour AA, Soliven B, Kennedy TE, Antel JP: Fingolimod (FTY720) enhances remyelination following demyelination of organotypic cerebellar slices. Am J Pathol 2010, 176:2682-2694
5. Rivera J, Proia RL, Olivera A: The alliance of sphingosine-1-phosphate and its receptors in immunity. Nat Rev Immunol 2008, 8:753-763
6. Mandala S, Hajdu R, Bergstrom J, Quackenbush E, Xie J, Milligan J, Thornton R, Shei GJ, Card D, Keohane C, Rosenbach M, Hale J, Lynch CL, Rupprecht K, Parsons W, Rosen H: Alteration of lymphocyte trafficking by sphingosine-1-phosphate receptor agonists. Science 2002, 296:346-349
7. Brinkmann V, Davis MD, Heise CE, Albert R, Cottens S, Hof R, Bruns C, Prieschl E, Baumruker T, Hiestand P, Foster CA, Zollinger M, Lynch KR: The immune modulator FTY720 targets sphingosine 1-phosphate receptors. J Biol Chem 2002, 277:21453-21457
8. Zhang Z, Zhang ZY, Fauser U, Schluesener HJ: FTY720 ameliorates experimental autoimmune neuritis by inhibition of lymphocyte and monocyte infiltration into peripheral nerves. Exp Neurol 2008, 210:681-690
9. Jaillard C, Harrison S, Stankoff B, Aigrot MS, Calver AR, Duddy G, Walsh FS, Pangalos MN, Arimura N, Kaibuchi K, Zalc B, Lubetzki C: Edg8/S1P5: an oligodendroglial receptor with dual function on process retraction and cell survival. J Neurosci 2005, 25:1459-1469
10. Miron VE, Jung CG, Kim HJ, Kennedy TE, Soliven B, Antel JP: FTY720 modulates human oligodendrocyte progenitor process extension and survival. Ann Neurol 2008, 63:61-71
11. Miron VE, Hall JA, Kennedy TE, Soliven B, Antel JP: Cyclical and dose-dependent responses of adult human mature oligodendrocytes to fingolimod. Am J Pathol 2008, 173:1143-1152
12. Gähwiler BH, Capogna M, Debanne D, McKinney RA, Thompson SM: Organotypic slice cultures: a technique has come of age. Trends Neurosci 1997, 20:471-477
13. Notterpek LM, Bullock PN, Malek-Hedayat S, Fisher R, Rome LH: Myelination in cerebellar slice cultures: development of a system amenable to biochemical analysis. J Neurosci Res 1993, 36:621-634
14. Haber M, Vautrin S, Fry EJ, Murai KK: Subtype-specific oligodendrocyte dynamics in organotypic culture. Glia 2009, 9:1000-1013
15. Miron VE, Zehntner SP, Kuhlmann T, Ludwin SK, Owens T, Kennedy TE, Bedell BJ, Antel JP: Statin therapy inhibits remyelination in the central nervous system. Am J Pathol 2009, 174:1880-1890
16. Ghoumari AM, Ibanez C, El-Etr M, Leclerc P, Eychenne B, O'Malley BW, Baulieu EE, Schumacher M: Progesterone and its metabolites increase myelin basic protein expression in organotypic slice cultures of rat cerebellum. J Neurochem 2003, 86:848-859